These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38607917)

  • 1. SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia.
    Meganck RM; Edwards CE; Mallory ML; Lee RE; Dang H; Bailey AB; Wykoff JA; Gallant SC; Zhu DR; Yount BL; Kato T; Shaffer KM; Nakano S; Cawley AM; Sontake V; Wang JR; Hagan RS; Miller MB; Tata PR; Randell SH; Tse LV; Ehre C; Okuda K; Boucher RC; Baric RS
    Cell Rep; 2024 Apr; 43(4):114076. PubMed ID: 38607917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic.
    Simmonds P
    mBio; 2024 Dec; 15(12):e0249324. PubMed ID: 39475243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    Richardson SI; Mzindle N; Motlou T; Manamela NP; van der Mescht MA; Lambson BE; Everatt J; Amoako DG; Balla S; von Gottberg A; Wolter N; de Beer Z; de Villiers TR; Bodenstein A; van den Berg G; Abdullah F; Rossouw TM; Boswell MT; Ueckermann V; Bhiman JN; Moore PL
    J Virol; 2024 Jul; 98(7):e0067824. PubMed ID: 38953380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications.
    Wooding D; Buist K; Romero-Ramirez A; Savage H; Watkins R; Bengey D; Greenland-Bews C; Thompson CR; Kontogianni N; Body R; Hayward G; Byrne RL; Gould S; ; Myerscough C; Atkinson B; Shaw V; Greenhalf B; Adams E; Cubas-Atienzar A; Khoo S; Fletcher T; Edwards T
    mSphere; 2024 Nov; 9(11):e0030424. PubMed ID: 39412283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of enhanced innate immune evasion by SARS-CoV-2.
    Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ
    Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
    Meehan GR; Herder V; Allan J; Huang X; Kerr K; Mendonca DC; Ilia G; Wright DW; Nomikou K; Gu Q; Molina Arias S; Hansmann F; Hardas A; Attipa C; De Lorenzo G; Cowton V; Upfold N; Palmalux N; Brown JC; Barclay WS; Filipe ADS; Furnon W; Patel AH; Palmarini M
    PLoS Pathog; 2023 Nov; 19(11):e1011589. PubMed ID: 37934791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
    Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
    Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air Travel.
    Tegally H; Wilkinson E; Martin D; Moir M; Brito A; Giovanetti M; Khan K; Huber C; Bogoch II; San JE; Tsui JL; Poongavanan J; Xavier JS; Candido DDS; Romero F; Baxter C; Pybus OG; Lessells R; Faria NR; Kraemer MUG; de Oliveira T
    medRxiv; 2022 Nov; ():. PubMed ID: 36451885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    Russell TW; Townsley H; Abbott S; Hellewell J; Carr EJ; Chapman LAC; Pung R; Quilty BJ; Hodgson D; Fowler AS; Adams L; Bailey C; Mears HV; Harvey R; Clayton B; O'Reilly N; Ngai Y; Nicod J; Gamblin S; Williams B; Gandhi S; Swanton C; Beale R; Bauer DLV; Wall EC; Kucharski AJ
    PLoS Biol; 2024 Jan; 22(1):e3002463. PubMed ID: 38289907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
    Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG
    EBioMedicine; 2024 Dec; 110():105415. PubMed ID: 39549677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Susceptibility of
    Mohl BP; Blaurock C; Breithaupt A; Riek A; Speakman JR; Hambly C; Bokelmann M; Pei G; Sadeghi B; Dorhoi A; Balkema-Buschmann A
    Viruses; 2024 Oct; 16(11):. PubMed ID: 39599832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.
    Sander AL; Yadouleton A; Moreira-Soto A; Tchibozo C; Hounkanrin G; Badou Y; Fischer C; Krause N; Akogbeto P; F de Oliveira Filho E; Dossou A; Brünink S; Drosten C; Aïssi MAJ; Harouna Djingarey M; Hounkpatin B; Nagel M; Drexler JF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern.
    Frasson I; Diamante L; Zangrossi M; Carbognin E; Pietà AD; Penna A; Rosato A; Verin R; Torrigiani F; Salata C; Dizanzo MP; Vaccaro L; Cacchiarelli D; Richter SN; Montagner M; Martello G
    J Mol Cell Biol; 2024 Aug; 16(3):. PubMed ID: 38305139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants.
    Zhu K; Sah M; Mahimainathan L; Liu Y; Xing C; Roush K; Clark A; SoRelle J
    Microbiol Spectr; 2024 Dec; ():e0138524. PubMed ID: 39660915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation.
    Syed AM; Ciling A; Chen IP; Carlson CR; Adly AN; Martin HS; Taha TY; Khalid MM; Price N; Bouhaddou M; Ummadi MR; Moen JM; Krogan NJ; Morgan DO; Ott M; Doudna JA
    PLoS Pathog; 2024 Nov; 20(11):e1012741. PubMed ID: 39571001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Braithwaite I; Aldridge RW; Hayward AC; White P; Jombart T; Cori A
    Lancet; 2022 Nov; 400 Suppl 1():S40. PubMed ID: 36929985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells.
    Do TND; Claes S; Schols D; Neyts J; Jochmans D
    Viruses; 2022 May; 14(5):. PubMed ID: 35632693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    Kakizaki M; Hashimoto R; Nagata N; Yamamoto T; Okura T; Katoh H; Kitai Y; Akahori Y; Shirato K; Ryo A; Takayama K; Takeda M
    J Virol; 2024 Nov; ():e0185324. PubMed ID: 39601592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.